A
vaginal yeast infection is considered to be recurrent
when you have had four or more symptomatic infections, unrelated to antibiotic
use, within 1 year. Severe or recurrent yeast infections are a problem for
about 5% of affected women, sometimes related to
diabetes, pregnancy, or a debilitating health
condition.1
If you have a recurrent
vaginal yeast infection, your doctor may do a
culture to confirm that yeast is present. You may also
be tested for certain conditions that could be making you more vulnerable to
yeast overgrowth, such as diabetes.
The recommended initial
treatment for recurrent vaginal yeast infections includes vaginal medicines for
7 to 14 days or a single dose of oral fluconazole 150 mg, with a second dose
repeated 3 days later.1
Initial treatment
is then followed by at least 6 months of maintenance therapy, which could be
oral or vaginal medicines. Current treatment recommendations are one of the
following:2
Clotrimazole vaginal suppositories, 500 mg, once
a week
Boric acid vaginal capsules, 600 mg, twice a week.1, 3 Boric acid can kill types of yeast
that can't be cured by azole antifungal medicines.3
Fluconazole, 100 mg to 150 mg, orally once a
week
Itraconazole, 400 mg, orally once a month or 100 mg, orally
once a day
Ketoconazole, 100 mg, orally once a day. Ketoconazole can have more
severe side effects. For this reason, it is not often used as treatment for
vaginal yeast infections.4
Some women who are treated for recurrent yeast infections do
not see improvement in their symptoms. These women may have another condition
that is causing symptoms similar to a yeast infection. Additional testing and
treatment may be needed.
Citations
Eschenbach DA (2003). Vaginitis section of Pelvic
infections and sexually transmitted diseases. In JR Scott et al., eds.,
Danforth's Obstetrics and Gynecology, 9th ed., pp.
585-589. Philadelphia: Lippincott Williams and Wilkins.
Centers for Disease Control and Prevention (2006).
Vulvovaginal candidiasis section of Sexually transmitted diseases treatment
guidelines, 2006. MMWR, 55(RR-11):
54-56.
Kessel KV, et al. (2003). Common complementary and
alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic
review. Obstetrical and Gynecological Survey, 58(5):
351-358.
Antifungal drugs (2008). Treatment Guidelines From the Medical Letter, 6(65): 1-8.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
Eschenbach DA (2003). Vaginitis section of Pelvic
infections and sexually transmitted diseases. In JR Scott et al., eds.,
Danforth's Obstetrics and Gynecology, 9th ed., pp.
585-589. Philadelphia: Lippincott Williams and Wilkins.
Centers for Disease Control and Prevention (2006).
Vulvovaginal candidiasis section of Sexually transmitted diseases treatment
guidelines, 2006. MMWR, 55(RR-11):
54-56.
Kessel KV, et al. (2003). Common complementary and
alternative therapies for yeast vaginitis and bacterial vaginosis: A systematic
review. Obstetrical and Gynecological Survey, 58(5):
351-358.
Antifungal drugs (2008). Treatment Guidelines From the Medical Letter, 6(65): 1-8.